From Nightmare Drug to Celgene Blockbuster, Thalidomide Is BackBy and
Whistleblower case unveils new details on drug’s comeback
Thousands of pages of documents recently unsealed in court
The modern drug-regulation system traces back to a once-popular morning-sickness pill whose linkage to babies born with flipper-like limbs in the 1960s led the U.S. to tighten oversight for approving medications.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.